Nektar Therapeutics has completed target enrollment for its phase 2b study of rezpegaldesleukin for the treatment of patients ...

The celebrity dermatologist talks about finding her moment of clarity in finding relief for her eczema symptoms and how she ...

Monthly tralokinumab is an effective dosing regimen for patients with atopic dermatitis who have achieved stable disease control.

This article also looks at causes, treatment options, and more. Atopic dermatitis ... The symptoms of dermatitis range from mild to severe. They can look different depending on what part of ...

Sanofi aims to boost competition in the atopic dermatitis market, following Dupixent's success, with new treatments like SAR444656 and amlitelimab in development.

Additionally, they may not provide lasting relief for all patients, especially those with moderate to severe forms of atopic dermatitis,” said Dr. Arora. “There are several new treatments for chronic ...

Shaperon secures phase 2 trials for atopic dermatitis treatment Nugel after positive review Shaperon obtains approval for ...

SAN CARLOS, CA and FORT WORTH, TX / ACCESSWIRE / / CAGE Bio, Inc., a clinical-stage biotechnology company advancing ...

Corvus Pharmaceuticals (CRVS) announced new interim data from the randomized, double-blind, placebo-controlled Phase 1 clinical trial ...

This includes significant responses in the soquelitinib treatment groups compared to placebo for ... 1 clinical trial is ...

Leading biopharmaceutical company Pfizer has unveiled Cibinqo and Staquis, two innovative therapies designed to address eczema across its varying stages, now available in Malaysia. The announcement, ...